Free Trial

Gossamer Bio (GOSS) Competitors

Gossamer Bio logo
$2.32 +0.23 (+10.77%)
As of 11:56 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

GOSS vs. ETNB, DNLI, SRPT, OCUL, DYN, VERA, ANIP, TLRY, COGT, and TWST

Should you be buying Gossamer Bio stock or one of its competitors? The main competitors of Gossamer Bio include 89BIO (ETNB), Denali Therapeutics (DNLI), Sarepta Therapeutics (SRPT), Ocular Therapeutix (OCUL), Dyne Therapeutics (DYN), Vera Therapeutics (VERA), ANI Pharmaceuticals (ANIP), Tilray Brands (TLRY), Cogent Biosciences (COGT), and Twist Bioscience (TWST). These companies are all part of the "pharmaceutical products" industry.

Gossamer Bio vs. Its Competitors

Gossamer Bio (NASDAQ:GOSS) and 89BIO (NASDAQ:ETNB) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their analyst recommendations, risk, earnings, profitability, institutional ownership, media sentiment, valuation and dividends.

Gossamer Bio currently has a consensus target price of $8.50, indicating a potential upside of 267.17%. 89BIO has a consensus target price of $25.81, indicating a potential upside of 74.11%. Given Gossamer Bio's stronger consensus rating and higher possible upside, research analysts clearly believe Gossamer Bio is more favorable than 89BIO.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Gossamer Bio
1 Sell rating(s)
0 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.67
89BIO
2 Sell rating(s)
5 Hold rating(s)
3 Buy rating(s)
1 Strong Buy rating(s)
2.27

81.2% of Gossamer Bio shares are owned by institutional investors. 6.7% of Gossamer Bio shares are owned by company insiders. Comparatively, 2.6% of 89BIO shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

89BIO has a net margin of 0.00% compared to Gossamer Bio's net margin of -344.81%. 89BIO's return on equity of -94.48% beat Gossamer Bio's return on equity.

Company Net Margins Return on Equity Return on Assets
Gossamer Bio-344.81% -1,774.72% -46.73%
89BIO N/A -94.48%-80.92%

In the previous week, 89BIO had 3 more articles in the media than Gossamer Bio. MarketBeat recorded 3 mentions for 89BIO and 0 mentions for Gossamer Bio. 89BIO's average media sentiment score of 0.49 beat Gossamer Bio's score of 0.00 indicating that 89BIO is being referred to more favorably in the news media.

Company Overall Sentiment
Gossamer Bio Neutral
89BIO Neutral

Gossamer Bio has a beta of 1.94, indicating that its share price is 94% more volatile than the S&P 500. Comparatively, 89BIO has a beta of 1.27, indicating that its share price is 27% more volatile than the S&P 500.

Gossamer Bio has higher revenue and earnings than 89BIO. 89BIO is trading at a lower price-to-earnings ratio than Gossamer Bio, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Gossamer Bio$114.70M4.59-$56.53M-$0.62-3.73
89BION/AN/A-$367.08M-$3.61-4.11

Summary

Gossamer Bio beats 89BIO on 11 of the 16 factors compared between the two stocks.

Get Gossamer Bio News Delivered to You Automatically

Sign up to receive the latest news and ratings for GOSS and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding GOSS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

GOSS vs. The Competition

MetricGossamer BioMED IndustryMedical SectorNASDAQ Exchange
Market Cap$524.11M$3.41B$6.17B$10.76B
Dividend YieldN/A2.26%5.72%4.83%
P/E Ratio-3.7223.4329.8328.61
Price / Sales4.59268.03500.08190.75
Price / CashN/A44.5736.5560.64
Price / Book17.8110.4012.016.60
Net Income-$56.53M-$52.53M$3.32B$276.84M
7 Day Performance5.71%1.42%1.31%1.83%
1 Month Performance-22.58%10.20%5.94%2.37%
1 Year Performance157.22%13.08%61.26%33.50%

Gossamer Bio Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
GOSS
Gossamer Bio
3.3343 of 5 stars
$2.32
+10.8%
$8.50
+267.2%
+135.1%$524.11M$114.70M-3.72180Gap Up
ETNB
89BIO
2.8583 of 5 stars
$14.80
flat
$25.81
+74.4%
+89.5%$2.19BN/A-4.1040Short Interest ↓
DNLI
Denali Therapeutics
4.1518 of 5 stars
$14.98
-2.5%
$33.50
+123.6%
-39.1%$2.19BN/A-5.35430
SRPT
Sarepta Therapeutics
4.5744 of 5 stars
$21.96
-0.7%
$34.42
+56.7%
-83.1%$2.15B$1.90B-25.241,372Analyst Forecast
OCUL
Ocular Therapeutix
4.2819 of 5 stars
$11.85
+0.6%
$22.63
+90.9%
+5.3%$2.06B$56.66M-9.26230
DYN
Dyne Therapeutics
3.0705 of 5 stars
$14.03
-0.1%
$34.07
+142.8%
-49.0%$2.00BN/A-3.63100Positive News
VERA
Vera Therapeutics
2.8752 of 5 stars
$30.49
+1.3%
$63.00
+106.6%
-29.3%$1.95BN/A-8.5240
ANIP
ANI Pharmaceuticals
3.7128 of 5 stars
$88.61
-1.3%
$99.14
+11.9%
+60.7%$1.92B$614.38M-115.08600
TLRY
Tilray Brands
3.1777 of 5 stars
$1.69
-1.7%
$2.00
+18.3%
-11.9%$1.86B$210.48M-0.742,842
COGT
Cogent Biosciences
2.3589 of 5 stars
$16.20
-0.4%
$20.00
+23.5%
+20.7%$1.84BN/A-9.1080Analyst Forecast
Gap Up
TWST
Twist Bioscience
3.7796 of 5 stars
$30.14
-3.4%
$48.50
+60.9%
-22.5%$1.82B$362.27M-20.79990Gap Up

Related Companies and Tools


This page (NASDAQ:GOSS) was last updated on 10/24/2025 by MarketBeat.com Staff
From Our Partners